Handelsbanken Fonder’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.1M | Sell |
14,695
-1,100
| -7% | -$82K | ﹤0.01% | 920 |
|
2025
Q1 | $1M | Hold |
15,795
| – | – | ﹤0.01% | 936 |
|
2024
Q4 | $1.23M | Sell |
15,795
-1,300
| -8% | -$101K | ﹤0.01% | 872 |
|
2024
Q3 | $1.37M | Buy |
17,095
+3,300
| +24% | +$265K | 0.01% | 807 |
|
2024
Q2 | $1.14M | Buy |
13,795
+4,400
| +47% | +$364K | 0.01% | 785 |
|
2024
Q1 | $802K | Hold |
9,395
| – | – | ﹤0.01% | 936 |
|
2023
Q4 | $803K | Hold |
9,395
| – | – | ﹤0.01% | 896 |
|
2023
Q3 | $842K | Hold |
9,395
| – | – | ﹤0.01% | 792 |
|
2023
Q2 | $800K | Hold |
9,395
| – | – | ﹤0.01% | 832 |
|
2023
Q1 | $777K | Hold |
9,395
| – | – | ﹤0.01% | 789 |
|
2022
Q4 | $739K | Hold |
9,395
| – | – | ﹤0.01% | 760 |
|
2022
Q3 | $696K | Hold |
9,395
| – | – | ﹤0.01% | 788 |
|
2022
Q2 | $612K | Hold |
9,395
| – | – | ﹤0.01% | 908 |
|
2022
Q1 | $594K | Hold |
9,395
| – | – | ﹤0.01% | 1083 |
|
2021
Q4 | $498K | Hold |
9,395
| – | – | ﹤0.01% | 1345 |
|
2021
Q3 | $663K | Hold |
9,395
| – | – | ﹤0.01% | 1151 |
|
2021
Q2 | $626K | Buy |
9,395
+500
| +6% | +$33.3K | ﹤0.01% | 1213 |
|
2021
Q1 | $987K | Hold |
8,895
| – | – | 0.01% | 848 |
|
2020
Q4 | $1.06M | Hold |
8,895
| – | – | 0.01% | 805 |
|
2020
Q3 | $776K | Hold |
8,895
| – | – | 0.01% | 805 |
|
2020
Q2 | $797K | Buy |
+8,895
| New | +$797K | 0.01% | 777 |
|